Financhill
Buy
59

ML Quote, Financials, Valuation and Earnings

Last price:
$87.67
Seasonality move :
-9.42%
Day range:
$86.11 - $87.22
52-week range:
$36.65 - $106.82
Dividend yield:
0%
P/E ratio:
116.13x
P/S ratio:
1.88x
P/B ratio:
3.39x
Volume:
119.4K
Avg. volume:
166.6K
1-year change:
42.2%
Market cap:
$986M
Revenue:
$545.9M
EPS (TTM):
$0.75

ML Analysts' Consensus Rating

The 5 analysts providing 12-month price projections for MoneyLion shares anticipate an average target of $94.25, ranging from a low estimate of $82.00 to a high estimate of $105.00. This average target implies a growth of 8.21% compared to the current stock price of $87.10.

Consensus Price Target

$94.25

Highest Price Target

$105.00

Lowest Price Target

$82.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 3 2 2

Hold 1 3 3

Sell 0 0 0
Consensus Buy Hold Hold

ML Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Is the Market Going to Go Lower?
Is the Market Going to Go Lower?

The last month has been extremely difficult for the stock…

2 Dividend Stocks to Buy in a Recession
2 Dividend Stocks to Buy in a Recession

While many economists and investors initially expected 2025 to be…

Stock Ideas

Buy
53
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
54
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
52
RGC alert for Mar 18

Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.

Buy
63
EXOD alert for Mar 18

Exodus Movement [EXOD] is down 3.96% over the past day.

Sell
45
MNPR alert for Mar 18

Monopar Therapeutics [MNPR] is up 0.93% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock